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The purpose of the present research was to determine if met-
alloproteinase levels were elevated in human chronic wound 
fluid. Samples of blood and wound fluid from acute (mastec-
tomy) and chronic (leg ulcer) wounds were collected, and 
metalloproteinase profiles of the samples were determined by 
gelatin zymography. Compared to serum, acute wound fluid 
(mastectomy fluid) contained markedly increased levels 
(five- to tenfold) of several metalloproteinases including 72-
kDa and 94-kDa gelatinases (MMP-2 and MMP-9). In 
C hronic skin ulcers are wounds that fail to heal [1,2]. To learn more about the defect(s) in these wounds, we began analyzing would fluid collected from be-neath occlusive dressings as an indicator of the wound environment [3,4] . Our studies showed that 
degradation of the adhesion proteins fibronectin and vitronectin 
occurred in chronic ulcers. Degradation was limited to the wound 
site since there was no evidence of adhesion protein degradation in 
blood samples obtained from the patients. Moreover, adhesion pro-
teins were intact in fluid obtained from acute wounds (suction blis-
ter Or mastectomy). Because fibronectin and other adhesion proteins 
are important for normal cutaneous repair [5]. degradation of the 
adhesion proteins in chronic ulcers could contribute to poor healing 
of these wounds. 
Degradation of adhesion proteins in chronic skin ulcers might 
occur as a result of uncontrolled proteinase activity in the wound 
bed. Little is known, however, about proteinase activity in human 
epidermal wounds. Elevated proteinase levels have been detected 
in blister fluid from bullous skin diseases [6,7] and corneal ulcers 
[8 -10]. Also, immunostaining of tissue sections with antibodies 
against interstitial collagenase showed elevated enzyme levels in 
active scar tissue [11]. 
Interstitial collagenase is part of a group of enzymes known col-
lectively as the matrix metalloproteinases. These zinc-dependent 
enzymes, including collagenases, gelatinases, and stromolysins, 
have homologous structures, are secreted in the form of latent 
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chronic wound fluid, not only were these enzyme levels 
increased another five- to tenfold over mastectomy fluid, but 
also both activated enzyme and proenzyme species appeared 
to be present. Our results suggest that non-healing ulcers 
develop an environment containing high levels of activated 
metalloproteinases, which may result in chronic tissue turn-
over and failed wound closure. ] Invest Dermatol1 01 :64- 68, 
1993 
proenzymes. and play important roles in various aspects of normal 
tissue repair and remodeling [12-15]. Several of the matrix metal-
loproteinases, including gelatinase (type IV collagenase), have been 
shown to degrade fibronectin and other adhesion proteins ill vitro 
[14.15]. To learn more about the possible role of these proteinases in 
non-healing ulcers, we collected would fluid samples from acute 
and chronic wounds, and analyzed proteinase profiles by gelatin 
zymography. Our results show that metalloproteinase levels were 
markedly increased in chronic wound fluid compared to acute 
wound fluid and that chronic wounds contain both proenzyme and 
activated enzyme species. 
EXPERIMENTAL DESIGN 
Collection and Preparation of Wound Fluids Informed con-
sent was obtained from individual subjects for all procedures. Sub-
jects with chronic leg ulcers or who had undergone surgical mastec-
tomy operations were recruited from in-patient and out-patient 
populations oflarge metropolitan hospitals in Dallas and New York 
City. Detailed descriptions of the procedures for wound fluid col-
lection and storage and methods for preparation of serum from 
plasma or blood have been reported previously [3,4J. The subject 
population used for these studies included six leg ulcer patients, ten 
mastectomy patients. and four normal volunteers. Leg ulcer pa-
tients, two women and four men, ranged in age from 37 to 79; 
mastectomy patients ranged in age from 39 to 71; and normal vol-
unteers, two women and two men, ranged in age from 32 to 35. 
Gelatin-Zymography Metalloproteinase profiles were deter-
mined by zymography using gelatin-containing acrylamide gels 
(8% acrylamide and 4.75 mg/ml gelatin) (16-18] . Samples of 
chronic wound fluid. mastectomy wound fluid , blood-derived 
serum (BDS), and plasma-derived serum (PDS) were subjected to 
sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) [19] under non-reducing conditions. Each lane was loaded 
with - 75 j1.g of protein [20] unless indicated otherwise. After elec-
trophoresis, gels were washed twice with 2.5% Triton-X-100 for 
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Figure 1. Gelatinase activity in serum derived from blood and plasma. 
Samples (75I1g) of DDS and PDS were subjected to gelatin zymography. 
Results shown from two different subjects are representative of the seven 
subjects studied. A 72-kDa gelatinase (MMP-2 proenzyme) was the predomi-
nant gelatinase in PDS, whereas DDS contained significant amounts of a 
94-kDa gelatinase (MMP-9 proenzyme) as well as MMP-2. 
30 min to remove SDS. They were then rinsed briefly with H 20 
followed by incubation overnight at 37"C in reaction buffer con-
taining 50 mM Tris-HCI, 150 mM NaCI, and 5 mM CaCl2 (pH 
7.4). In studies to determine enzyme specificity, proteinase inhibi-
tors were added to wash or reaction buffer solutions as indicated. At 
the end of the incubations, the gels were stained with 0.1 % Coo-
massie brilliant blue and destained . Areas of proteinase activity ap-
peared as clear zones against a dark blue background. Bio-Rad high 
molecular weight standards were used for molecular mass markers. 
RESULTS 
Gelatinase Activity in Serum Derived from Blood and 
Plasma Because the overall protein profi le of wound fluid was 
found to be similar to serum [3,4]' we examined the gelatinase 
profile of serum to assess baseline levels of proteinases that might 
occur in wound fluid. Serum was prepared both from plasma (PDS) 
and from blood (BDS). making it possible to distinguish between 
circulating gelatinases and gelatinases released from blood cells dur-
ing clot formation. 
Figure 1 shows representative zymograms for two of four sub-
jects. As indicated in Materials alld Methods, zymograms utilize gela-
tin co-polymerized with acrylamide. After removal ofSDS from the 
gels, the gelatin can be degraded by gelatinases that are present in 
the samples. When the gels are subsequently stained for protein, 
clear areas in the otherwise dark background identify the location of 
enzymatic activity. Because the active site of latent metalloprotein-
ases becomes available after SDS treatment, this method detects 
gelatinases even if they are still in the proenzyme for~ [17]. . 
PDS contained primarily a 72-kDa gelatll1ase, a findl11g consist-
ent with previous studies [21]. Blood-derived serum contained 72-
kDa gelatinase and also a 94-kDa gelatinase, indicating that the 
latter was released from blood cells during clotting. Based on their 
molecular masses, the 72-kDa and 94-kDa gelatinases correspond to 
the proenzyme forms of the enzymes designated MMP-2 and 
MMP-9 [22]. Also, less prominent 130- and 225-kDa gelatlnases 
were detected. These bands probably represented complexes be-
tween the 94-kDa gelatinase and other molecules (e.g., metallopro-
teinase inhibitors). Such complexes have been shown previously to 
be released by neutrophils [23] and monocytes [24] . 
Gelatinase Activity in Mastectomy Wound Fluid The above 
results established baseline gelatinase profiles in serum. We also 
METALLOPROTEINASES IN WOUND FLUID 65 
MF-l-l MF-1-2 MF-2-1 MF-2-2 
* MMP-9 
* MMP-2 
Figure 2. Gelatinase activity in mastectomy wound fluid. Samples (75/lg) 
of mastectomy wound fluid collected from patients 1 and 2 d after surgery 
were subjected to gelatin zymography. Results shown from two different 
subjects are representative of the 10 subjects studied. Compared to serum, 
mastectomy fluid contained elevated levels ofMMP-2 and MMP-9 as well as 
putative 130-kDa and 225-kDa MMP-9 complexes. 
studied gelatinase profiles during acute inflammation. As an exam-
ple of acute wound fluid, we used mastectomy fluid. Gelatinase 
patterns observed in samples from ten patients were all similar, and 
Figure 2 shows representative zymograms for two subjects whose 
wound fluid samples were obtained days 1 and 2 after surgery. The 
group of four gelatinase bands that we~e observed in blood-derived 
serum were also the predominant gelatmases 111 mastectomy wound 
fluid: that is, MMP-2, MMP-9, and the 130-kDa and 225-kDa 
bands believed to be MMP-9 - containing complexes. 
Enzymatic activity on zymograms was quantified by scanning 
densitometry of the bands and measuring the area under the peaks. 
One zymogram unit was defined as activity corresponding to an 
area ofl mm2 . Figure 3 shows a plot ofMMP-2 and MMP-9 gelatin-
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Figure 3. Analysis of zymograms by scanning densitometry. Samples of 
mastectomy wound fluid as indicated were subjected to zymography. Zy-
mograms were photographed to obtain negatives, and the negatives were 
analyzed using a scanning laser densitometer (LKB Ultrascan). Areas corre-
sponding to the MMP-2 and MMP-9 bands on the negatives-clear zones 
on the originals -were quantified with a digitizing pad. One zymography 
using equals an area of 1 mm2. Data shown are for two different mastectomy 
fluid samples. 
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Table I. Concentration of Gelatinases in Serum and Wound Fluid' 
Gelatinase Activity (Zymography Units) 
Protein 72 kDa 94 kDa 
Experiment Sample (jtg) (MMP-2) (MMP-9) 130 kDa 225 kDa 
PDS 75 4.5 ± 0.4' 0 .6 ± 0 .3 
BDS 75 4.4 ± 0.3 5.0 ± 2.0 
2 MF 75 8.6 ± 2.9 23.3 ± 3.8 
3 PDS 75 
BDS 75 
MF 75 



























, Gelatinase activity was determined as described in the legend ro Fig 3. Experiment 1: samples (75 Jlg) ofPDS and DDS from four different subjects. Experiment 2: samples (75Jlg) 
of five different mastectomy wound fluids. Experiment 3: samples (75 Jlg) ofPDS, BDS, and mastectomy wound fluid. Experiment 4: samples (2J.1g) of mastectomy wound fluid and 
chronic wound fluid . 
• Mea n ± SO. 
ase activity versus concentration of mastectomy fluid for two differ-
ent mastectomy fluid samples. The results show a relatively linear 
dose-response relationship for activity measured by densitometry, 
particularly at enzyme activities less than 10 units. 
Table I, experiment 1 shows another experiment in which 75-flg 
samples of PDS and BDS from four different subjects were ana-
lyzed. As was evident from Fig 1, MMP-2 levels were similar to 
PDS and BDS. MMP-9 levels were about ninefold higher in BDS 
compared with PDS. Table I, experiment 2 shows a similar analysis 
for five different mastectomy samples. The results in Fig 3 and 
Table I, experiments 1 and 2, indicate that, for samples analyzed on 
the same zymogram, densitometric analysis provides a high degree 
of precision. Nevertheless, there was some variability in the results 
from day to day, partly as a result of slight changes in the gels, but 
especially because the gels were photographed to optimize visualiza-
tion of the bands. 
Comparison of experiments 1 and 2 in Table I show that MMP-2 
levels were about twofold higher in mastectomy fluid than in PDS 
and BDS, and MMP-9 levels were at least fivefold higher than in 
PDS. Considering the results in Fig 3, the latter value is a conserva-
tive estimate. When representative samples ofPDS, BDS, and mas-
tectomy fluid were analyzed on the same zymogram (Table I, ex-
periment 3), the levels of MMP-2 were about threefold higher in 
mastectomy fluid than in BDS or PDS, whereas the levels of MMP-
2 or MMP-9 - containing complexes were more than tenfold higher 
in mastectomy fluid. These data provide direct evidence for in-
creased MMP-9 levels during the acute inflammatory response ill 
vivo, which most likely resulted from release of MMP-9 by neutro-
phils and monocytes that migrated into the wound bed [23,24]. On 
the other hand, MMP-2 remained closer to basal levels, as would be 
expected at the early stages of repair before granulation tissue for-
mation, assuming that fibroblasts are the major source of this en-
zyme [25] . 
Gelatinase Activity in Chronic Wound Fluid When the gela-
tinase profiles of wound fluid obtained from six patients with 
chronic leg ulcers were compared with serum or mastectomy fluid, 
there were several significant differences. First, there was not a 
single proteinase pattern common to all of the patients . Figure 4 
shows samples collected from four patients, two in Dallas (DA) and 
two in New York City (NY). Four of the six patients had gelatinase 
profiles similar to DA-1 and NY -1, but DA-2 and NY -2 were 
unique. Consistent with previous studies [4], changes in gelatinase 
levels occurred locally, not systemically, because blood samples col-
lected from the Dallas patients showed only baseline gelatinase 
levels (data not shown). 
Second, the gelatinase profiles of chronic wound fluid were much 
more complex than those of mastectomy wound fluid or serum. 
Rather than four gelatinase bands, there were seven or more. Of 
particular interest were the bands that appeared just beneath MMP-
2 and MMP-9, - 8 kDa smaller (see also Fig 5). This pattern would 
be expected if the proenzyme forms of the enzymes had been 
cleaved to the slightly smaller activated forms. Chronic wound 
fluids DA-2 and NY-2 also contained several gelatinases less than 
45 kDa that we have yet to identify. 
Finally, the gelatinase levelsin chronic wound fluid were higher 
than in mastectomy wound fluid. This difference is illustrated by 
Fig 5, which shows a zymogram of serial dilutions of two chronic 
wound fluid samples compared to each other and to mastectomy 
wound fluid. Table I, experiment 4 shows a comparison of gelatin-
ase activity levels in samples diluted to 2 flg. MMP-2 levels in 
chronic wound fluid were three- to fivefold higher than in mastec-
tomy fluid, and MMP-9 levels were five- to twentyfold higher than 
in mastectomy fluid. In other experiments, analysis of serial dilu-
tions of chronic wound fluids NY -1 and NY -2 indicated that 
MMP-2 and MMP-9 levels in these samples were intermediate be-
tween DA-l and DA-2 (data not shown). 
Table II. Effect of Proteinase Inhibitors on Gelatin Zymographic Activity· 
Inhibitor Specificity Concentration Effect on Zymogram 
Ethylenediaminetetraacetic acid Metallo 10mM Complete inhibition 
1,10-phenanthroline Metallo 5mM Complete inhibition 
AEBSF Serine 10mM No effect 
Phenylmethylsulfonylfluoride Serine 0.2mM No effect 
Tosyllysyl chloromethyl ketone Serine 100 jtM No effect 
Tosyl phenylalanyl chloromethyl ketone Serine 100 jtM No effect 
Aprotinin Serine 20 11M No effect 
Leupeptin Serine/cysteine 20jtM No effect 
Pepstatin A Aspartic 20 11M No effect 
• Samples of serum or mastectomy fluid (75 Jlg) or chronic wound fluid (2-10 Jlg) were subjected to gelatin zymography. Inhibitors were added to the overnight reaction buffer at 
the concentrations indicated. In some experiments, the inhibitors AEBSF and aprotinin were added to the wash buffer as well as the reaction buffer. AEBSF was purchased from 
Calbiochem, and all other inhibitors were obtained from Sigma Chemical Co. 
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Figure 4. Gelatinase activity in chronic wound fluid . Samples (75 Jig) of 
chronic wound fluid were subjected to gelatin zymography. Results shown 
arc from four different subjects, two whose wound fluid was collected in 
Dallas (DA) and two whose wound fluid was collected in New York (NY). 
Gclatinase profiles observed with DA-I and NY-I were typical of six of the 
eight subjects studied. Chronic wound fluid contained several gelatinases 
not found in mastectomy fluid including components -8 kDa smaller than 
MMP-2 and MMP-9, possibly corresponding to activated MMP-2 and 
MMP-9 enzymes. 
Effect of Proteinase Inhibitors on Wound Fluid Gclatinases 
The above results showed that chronic wound fluid contained 
higher levels of gelatinases than mastectomy wound fluid and also 
contained what appeared to be activated forms of gelatinase that 
were absent from mastectomy wound fluid . To confirm that these 
gelatinases were metalloproteinases, enzyme inhibitor studies were 
performed. Table II summarizes the reagents that were tested 
in these studies. Addition of the metalloproteinase inhibitors ethy 1-
enediaminetetraacetic acid or l,10-phenanthroline to the zymo-
graphy reaction buffer resulted in a complete inhibition of all zy-
mography bands detected in serum, mastectomy wound fluid , and 
chronic wound fluid . On the other hand, addition of other inhibi-
tors had no detectable effect, even if they were added to both the 
wash solution and reaction buffer. In control experiments, amin-
oethylbenzene su lfonylfluoride (AEBSF) and aprotinin were shown 
to inhibit zymography bands observed with trypsin and plasmin, 
whereas trypsin activity was unaffected by l,10-phenanthroline 
(data not shown) . 
DISCUSSION 
We used gelatin zymography [17) to compare metalloproteinase 
profiles in chronic wound fluid with acute wound fluid and serum. 
Analysis of wound fluid as an indicator of the wound environment is 
a useful method for studying chronic ulcers because the fluid can be 
obtained non-invasively by briefly covering the patient'S ulcer with 
an occlusive dressing. Although there may be some molecules selec-
tively retained in the wound bed, the overall polypeptide profiles of 
chronic and acute wound fluid and serum were found to be similar 
[3 ,4). Moreover, even large matrix molecules such as cellular fibro-
nectin diffused through the wound bed into the wound fluid [4) . 
Serum was used to assess baseline levels of proteinases that might 
occur in wound fluid, and mastectomy fluid was used to assess 
changes in proteinases associated with the acute inflammatory re-
sponse. Plasma-derived serum contained primarily MMP-2 (72-
kDa gelatinase) consistent with a previous report [21]. Blood-der-
ived serum contained MMP-2 and in addition MMP-9 and 
MMP-9-containing complexes, indicating that cellular release of 
this enzyme occurred during clotting, probably from neutrophils 
and monocytes [23,24] . Acute wound fluid (mastectomy fluid) con-
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tained the same group of four gelatinase bands as blood-derived 
serum but at higher levels, approximately threefold higher MMP-2 
and more than tenfold higher MMP-9. N evertheless, only proen-
zyme forms of MMP-2 or MMP-9 were detected. Therefore, al-
though the initial inflammatory response after wound healing re-
sulted in increased proenzyme accumulation, the proenzymes did 
not appear to become activated. It should be noted that our identifi-
cation of MMP-2 and MMP-9 has been based solely on zymo-
graphic results, and studies with specific antibody reagents have yet 
to be carried out. 
Higher levels of MMP-9 compared to MMP-2 after initial 
wounding are consistent with inflammatory cells as the major 
source of MMP-9 and fibrobl as ts as the major source of MMP-2 
[23 - 25). Assuming that MMP-9 in the wound bed comes mostly 
from inflammatory cells, the MMP-9/MMP-2 ratio may provide an 
index of inflammation. In rabbit corneal keratectomy wounds, 
which involve a minimal inflammatory response, the MMP-9/ 
MMP-2 ratio remained quite low [26). Our studies showed that the 
MMP-9/ MMP-2 ratio was lowest in PDS, intermediate in mastec-
tomy fluid, and hi ghest in chronic wound fluid . Therefore, chronic . 
wounds may represent a persistent inflammatory state, which could 
have a variety of causes, including the presence of focal bacterial 
colonies in the wound bed [27 -29). 
Metalloproteinase levels in chronic wound fluid were much 
higher than in mastectomy fluid or serum. Moreover, unlike mas-
tectomy fluid, the gelatinase profiles of chronic wound fluid 
showed several bands in addition to the proenzyme forms of the 
metalloproteinases. Although we have studied only a small patient 
population so far, these differences observed were found with pa-
tients from different geographic locations and with wound fluid 
samples collected by different investigators . 
Gelatinase bands that appeared - 8 kDa smaller than MMP-2 and 
MMP-9 would be expected if the proenzyme forms of the enzymes 
had been cleaved to the slightly smaller activated enzyme species. 
The irr vivo mechanism of activation of these collagenases is as yet 
unknown [14,15] . Plasmin, which has been suggested to initiate 
activation of interstitial collagenase and stromolysin [30]. probably 
is not responsible for activation of the MMP-2 and MMP-9 [31) . A 
variety of serum and tissue froteinase inhibitors normally regulate 
proteinase activity [12 - 15 . Therefore, metalloproteinase activa-
tion in chronic wounds could result from increased levels of an 
activator or decreased levels of an inhibitor. Future studies on 
chronic wound fluid should provide an opportunity to learn more 
about the ill vivo regulatory mechamsms for MMP-2 and MMP-9. 
The increased level and activation of metalloproteinases in 
HF-l CWF-DA-l CWF- DA-Z 
UG 50 10 . 4 50 10 . 4 50 10 
.4 
Figure 5. Comparison of gelatinase activities in mastectomy and chronic 
wound fluids. Serially-diluted samples of mastectomy wound fluid and 
chronic wound fluids DA- t and DA-2 (50 - 0.4 Jig) were subjected to gelatin 
zymography. Comparison of the profiles at different sample sizes showed 
that gelatinase levels were higher in chronic wound fluids than in mastec-
tomy wound fluid. Also, gelatinase levels in chronic wound fluid DA-2 were 
higher than in DA-1. 
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chronic wound fluid may be responsible, at least in part, for degrada-
tion of adhesion pr?teins that occurs in chronic wound fluid but not 
In acute wound flUid [3,4]. ConSIStent With this Idea, the proteinase 
levels in chronic wound fluid DA-2 were higher than DA-l, and 
fibronectin and vitronectin were more completely degraded in DA-
2 wound fluid than in DA-l wound fluid [4] . Recently, we also have 
observed a correlation between high gelatinase levels and the extent 
of adhesion protein degradation in acute burn fluid {Grinnell and 
Zhu, unpublished observations}. 
Because fibronectin and other adhesion proteins are important for 
normal wound repair [5] , degradation of the adhesion proteins by 
proteinases in chronic ulcers could contribute to poor healing of 
these wounds. Moreover, fibronectin fragments may help maintain 
high proteinase levels by stimulating neutrophil degranulation [32] 
and fibroblast secretion of metalloproteinases [33]. Also, some fibro-
nectin fragments exhibit endogenous proteinase activity towards 
gelatin and lam inin [34]. Finally, elevation of proteinases in wound 
fluid could interfere with normal healing not only by degrading 
adhesion proteins, but also by degrading other factors necessary for 
repair. Therefore, chronic tissue degradation caused by an environ-
ment containing high levels of activated metalloproteinases may 
playa major role in failed wound closure. 
These studies were supported by NIH grallis NR06263 (AW), GM26145, 
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